MapLight Therapeutics planned sale of 33,605 shares

MapLight Therapeutics, Inc. reports that Anatol Kreitzer has filed a notice to sell up to 33,605 shares of MapLight voting common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of 1273966.00, around July 15, 2026 on Nasdaq.

Rhea-AI Filing Summary

MapLight Therapeutics, Inc. reports that Anatol Kreitzer has filed a notice to sell up to 33,605 shares of MapLight voting common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of 1273966.00, around July 15, 2026 on Nasdaq.

Shares of this class outstanding were 42,618,165. During the past three months, Kreitzer sold 3,316 shares for 88239.00 on April 15, 2026 and 45,422 shares for 1347066.00 on April 27, 2026.

Key Figures

Shares to be sold: 33,605 shares Aggregate market value: 1273966.00 Shares outstanding: 42,618,165 shares +3 more

6 metrics

Shares to be sold 33,605 shares Proposed sale of MapLight voting common stock

Aggregate market value 1273966.00 Planned sale of 33,605 shares of MapLight voting common stock

Shares outstanding 42,618,165 shares Number of MapLight voting common shares outstanding

Prior sale 1 3,316 shares for 88239.00 Sale of MapLight voting common stock on 04/15/2026

Prior sale 2 45,422 shares for 1347066.00 Sale of MapLight voting common stock on 04/27/2026

Approximate sale date 07/15/2026 Planned date for sale of 33,605 shares on Nasdaq

Key Terms

Restricted stock unit settlement, aggregate market value, Securities Sold During The Past 3 Months

3 terms

Restricted stock unit settlement financial

"MapLight voting common stock | 07/15/2026 | Restricted stock unit settlement"

aggregate market value financial

"33605 | 1273966.00 | 42618165 | 07/15/2026 | Nasdaq"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Securities Sold During The Past 3 Months regulatory

"144: Securities Sold During The Past 3 Months"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale is disclosed for MapLight Therapeutics (MPLT)?

Anatol Kreitzer plans to sell up to 33,605 shares of MapLight voting common stock. The filing lists an aggregate market value of 1273966.00 and identifies Morgan Stanley Smith Barney LLC as the broker, with sales expected around July 15, 2026 on Nasdaq.

How many MapLight Therapeutics (MPLT) shares are outstanding in this notice?

The notice lists 42,618,165 shares of MapLight voting common stock outstanding. This figure provides context for the planned sale of 33,605 shares, indicating the filing relates to a relatively small portion of the total outstanding equity of this class.

What is the acquisition source of the shares Anatol Kreitzer plans to sell in MPLT?

The 33,605 MapLight voting common shares are shown as arising from a restricted stock unit settlement dated July 15, 2026. The issuer is identified as MapLight Therapeutics, Inc., with the transaction nature specifically described as a restricted stock unit settlement.

What prior sales did Anatol Kreitzer report for MapLight Therapeutics (MPLT)?

During the past three months, Kreitzer reported selling 3,316 shares for 88239.00 on April 15, 2026. He also sold 45,422 shares for 1347066.00 on April 27, 2026, both transactions involving MapLight voting common stock.

Which broker is handling the planned MapLight Therapeutics (MPLT) share sale?

The planned sale of 33,605 shares of MapLight voting common stock will be handled by Morgan Stanley Smith Barney LLC. The broker’s address is given as 1 New York Plaza, 8th Floor, New York, NY 10004, and the shares are expected to trade on Nasdaq.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/15/2026 - 07:56 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002021238
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	MapLight Therapeutics, Inc.
SEC File Number	001-42914
Address of Issuer	800 Chesapeake Drive Redwood City CALIFORNIA 94063
Phone	(617)-984-6300
Name of Person for Whose Account the Securities are To Be Sold	Anatol Kreitzer
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
MapLight voting common stock	Morgan Stanley Smith Barney LLC 1 New York Plaza 8th Floor New York NY 10004	33605	1273966.00	42618165	07/15/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
MapLight voting common stock	07/15/2026	Restricted stock unit settlement	MapLight Therapeutics, Inc.			33605	07/15/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Anatol Kreitzer 800 Chesapeake Drive Redwood City CA 94063	MapLight voting common stock	04/15/2026	3316	88239.00
Anatol Kreitzer 800 Chesapeake Drive Redwood City CA 94063	MapLight voting common stock	04/27/2026	45422	1347066.00

144: Remarks and Signature

Remarks	Shares to be sold solely to satisfy tax-withholding obligations in connection with restricted stock unit vesting.
Date of Notice	07/15/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Anatol Kreitzer
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)